Kamada (KMDA) EPS (Diluted) (2015 - 2026)
Powered by 
Analysis
Kamada (KMDA) EPS (Diluted) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | -0.40 |
| 10 | Kamada | 473.28 Mn | 403.14 Mn | 22.47 Mn | 0.19 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.19 |
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | -0.09 |
| Mar 31, 2022 | -0.04 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.02 |